• $1.5M
    Market Cap
  • 139.27%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2024
12/31/2023
12/31/2022
08/31/2021
Income Statement
Total Operating Revenue
1.1M
+42.27%
785,453
+22,954.09%
3,407
N/A
N/A
N/A
Cost of Revenue
664,517
+50.24%
442,289
+38,393.39%
1,149
-91.53%
13,569
+287.13%
Gross Profit
452,935
+31.99%
343,164
+15,097.70%
2,258
-89.73%
21,997
+383.56%
Sales and Marketing Expense
1.3M
-19.37%
1.6M
-57.60%
3.7M
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
9,637
+7.46%
8,968
N/A
N/A
N/A
3,244
+15.98%
Total Operating Expenses
1.4M
-20.25%
1.8M
-54.88%
4.0M
+307.35%
987,574
-75.43%
Operating Profit
-994,628
-32.43%
-1.5M
-63.39%
-4.0M
+316.40%
-965,577
-75.95%
Interest Income
N/A
N/A
N/A
N/A
931
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
-100.00%
931
N/A
0
+100.00%
Total Nonoperating Income and Expense
-42,847
+294.36%
-10,865
-88.63%
-95,572
N/A
N/A
N/A
Income before Taxes
-1.0M
-30.03%
-1.5M
-63.98%
-4.1M
+326.30%
-965,577
-79.19%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.0M
-30.03%
-1.5M
-63.98%
-4.1M
+326.30%
-965,577
-79.19%
Net Income from Continuing Operations Applicable to Common
-1.0M
-30.03%
-1.5M
-63.98%
-4.1M
+326.30%
-965,577
-79.19%
Basic EPS and Net Income
-0.10
-33.33%
-0.15
-65.91%
-0.44
N/A
0.00
+100.00%
Diluted EPS and Net Income
-0.10
-33.33%
-0.15
-65.91%
-0.44
N/A
0.00
+100.00%
Basic Weighted Average Shares
10.5M
+3.54%
10.2M
+8.55%
9.4M
-95.97%
232.2M
+95.34%
Diluted Weighted Average Shares
10.5M
+3.54%
10.2M
+8.55%
9.4M
-95.97%
232.2M
+95.34%
Balance Sheet
Cash and Cash Equivalents
60,305
+812.74%
6,607
-72.96%
24,433
+118.60%
11,177
-91.17%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
60,305
+812.74%
6,607
-72.96%
24,433
+118.60%
11,177
-91.17%
Total Current Assets
165,257
+101.93%
81,839
-26.75%
111,732
+25.50%
89,027
-32.81%
Accumulated Depreciation
18,605
+107.46%
8,968
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
31,342
-23.52%
40,979
+311.97%
9,947
+262.37%
2,745
N/A
Total Long-Term Assets
31,342
-23.52%
40,979
+311.97%
9,947
+262.37%
2,745
N/A
Total Assets
359,088
+1.33%
354,360
-13.48%
409,591
+228.94%
124,520
-25.10%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
20,000
N/A
N/A
N/A
415,500
-16.99%
500,534
-19.27%
Total Current Liabilities
1.1M
+3.68%
1.1M
+24.64%
865,648
+59.49%
542,762
-20.17%
Total Long-Term Debt
1.3M
+48.31%
849,500
N/A
N/A
N/A
100,000
N/A
Total Long-Term Liabilities
922,004
-7.80%
999,960
+362.86%
216,039
N/A
N/A
N/A
Total Liabilities
2.5M
+17.90%
2.1M
+92.19%
1.1M
+99.29%
542,762
-20.17%
Retained Earnings
-26.4M
+4.09%
-25.4M
+6.21%
-23.9M
+20.98%
-19.7M
+5.14%
Total Stockholders Equity
-2.1M
+21.30%
-1.7M
+156.59%
-672,096
+60.70%
-418,242
-18.58%
Total Shares Outstanding
11.2M
+9.68%
10.2M
+2.24%
9.9M
-95.97%
246.9M
+27.01%
Cash Flow
Cash from Operating Activities
-289,802
-30.20%
-415,198
-47.97%
-798,067
-23.33%
-1.0M
+123.75%
Capital Expenditures
600,000
N/A
N/A
N/A
7,202
+162.37%
2,745
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
-87,971
+1,661.18%
-4,995
N/A
Dividends Paid
N/A
N/A
N/A
N/A
4,793
N/A
N/A
N/A
Cash from Financing Activities
343,500
-13.56%
397,372
-47.87%
762,243
-18.09%
930,534
+60.02%
Financials Ratio
Gross Margin
40.53%
-7.23%
43.69%
-34.08%
66.28%
N/A
N/A
N/A
Operating Margin
-89.01%
-52.50%
-187.40%
-99.84%
-118,011.59%
N/A
N/A
N/A
Return on Assets
-290.83%
-25.08%
-388.20%
-74.81%
-1,541.34%
+132.07%
-664.16%
-82.42%
Return on Equity
54.37%
-56.06%
123.74%
-83.61%
755.04%
+264.35%
207.23%
-87.83%
Revenue Growth
42.27%
-99.82%
22,954.09%
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.15
+94.60%
0.08
-41.21%
0.13
-21.28%
0.16
-15.85%
Cash Ratio
0.05
+783.61%
0.006
-78.37%
0.03
+36.89%
0.02
-88.94%
Debt-to-Equity Ratio
-0.61
N/A
N/A
N/A
N/A
N/A
-1.44
N/A
Debt-to-Assets Ratio
3.56
N/A
N/A
N/A
N/A
N/A
4.82
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow